Startups channel feed – Endpoints News

Startups channel feed

With Forty Seven co-founder at the helm, new biotech spinout launches to target mutations potentially linked to numerous diseases

4 years ago

A new Third Rock startup seeks a 'second golden age' of GPCR drug discovery based on Nobel laureate's work

4 years ago

Backed by Bayer's Leaps, Boston-based Cellino lands $80M for cell therapy-in-box

4 years ago

OrbiMed takes point on a new biotech launch, but almost everything remains secret for now

4 years ago

A new startup wants to take antisense and siRNA one step further, and build more potent drugs than Ionis and Alnylam

4 years ago

British billionaire Mike Platt hops on board a London startup looking at drug discovery from a different angle

4 years ago

Antibody legend Tillman Gerngross introduces his latest company, with an Innovent deal already lined up

4 years ago

Bob Nelsen, Anne Wojcicki join $20M round for longevity startup hoping to slow down aging of the ovary

4 years ago

A new AI startup has emerged, and Pfizer likes what it sees

4 years ago

A new startup thinks it's found a key to drugging 'disordered' proteins — and it has plenty of cash to get started

4 years ago

Biosimulation outfit nets $15M Series A in push to make preclinical R&D more predictable

4 years ago

Taking notes from MD Anderson and Rice University, Avenge Bio uncloaks with $45M and a slate of immunotherapies

4 years ago

After 7 years in stealth, UC Berkeley spinout Nodexus emerges with an RA Capital-backed Series A

4 years ago

A new eye-focused biotech is out of stealth, with plans to barrel toward PhII studies

4 years ago

Atlas, F-Prime launch K36 Therapeutics to advance oncology molecule for elusive epigenetic target

4 years ago

Newpath Partners kicks off $350M fund with a wunderkind holding the bag and an all-star scientific team waiting in the wings

4 years ago

Icelandic billionare's biosimilar company raises $450M, preps for Nasdaq launch with SPAC merger

4 years ago

Always busy, Gary Glick recruits OrbiMed in a massive $218M Series A for enigmatic data science biotech

4 years ago

Transpacific AI biotech makes its Series A debut — putting $86M in the bank

4 years ago

Apple Tree Partners leaps across the pond to launch a UK biotech looking to crack the secrets of dendritic cells

4 years ago

Ex-Novartis business head hops over to a gene therapy startup — and she's reeled in $80M for a dash to the clinic

4 years ago

Another epigenome editing startup launches from a pair of the field’s longtime leaders

4 years ago

Looking to run with Big Pharma, a radiopharma startup with backing from Atlas, RA thinks it has the chops to compete

4 years ago

After Big Pharma sparked interest in the US, Ablaze looks to bring radiopharmaceuticals overseas

4 years ago

First page Previous page 43 44 454647 48 49 Next page Last page